Viatris VTRS
NASDAQ VTRS
$16.53 -0.08 (-0.45%)
As of: Sep 9, 2026 · 3:49 PM EDT

Viatris (VTRS) Cash & Equivalents (2019 - 2026)

Viatris (VTRS) posted Cash & Equivalents of $886.5 million for Q2 2026, down 50.86% on a QoQ basis from $1.8 billion in Q1 2026, and up 56.51% year-over-year from $566.4 million in Q2 2025.

Analysis

Viatris (VTRS) Cash & Equivalents (2019 - 2026) Analysis & Trends

Viatris has reported Cash & Equivalents for 8 years, with the latest figure at $886.5 million in Q2 2026.

  • On a quarterly basis, Cash & Equivalents rose 56.51% year-over-year to $886.5 million in Q2 2026; TTM through Jun 2026 was $886.5 million, a 56.51% increase from a year earlier, with the FY2025 full-year figure at $1.3 billion, up 79.65% from the prior year.
  • Cash & Equivalents was $886.5 million for Q2 2026 at Viatris, down from $1.8 billion in the prior quarter.
  • The five-year high for Cash & Equivalents was $1.9 billion in Q3 2024, with the low at $506.6 million in Q1 2023.
  • Average Cash & Equivalents over 5 years is $978.9 million, with a median of $901.8 million recorded in 2024.
  • The sharpest annual moves came in 2025 and 2026: Cash & Equivalents sank 48.09% in 2025, then soared 138.97% in 2026.
  • Over 5 years, Cash & Equivalents stood at $1.3 billion in 2022, then fell by 21.43% to $991.9 million in 2023, then decreased by 25.79% to $736.1 million in 2024, then surged by 79.65% to $1.3 billion in 2025, then plunged by 32.96% to $886.5 million in 2026.
  • The last three Cash & Equivalents figures came in at $886.5 million (Q2 2026), $1.8 billion (Q1 2026), and $1.3 billion (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Teva Pharmaceutical Industries 42.53 Bn 38.88 Bn 2.15 Bn 3.66 Bn
2 Viatris 19.14 Bn 18.25 Bn 1.46 Bn 886.50 Mn
3 Dr Reddys Laboratories 9.86 Bn 9.69 Bn 396.53 Mn 118.35 Mn
4 Amneal Pharmaceuticals 5.45 Bn 5.33 Bn 334.51 Mn 127.64 Mn
5 Bausch Health Companies 2.33 Bn 492.63 Mn 2.10 Bn 1.83 Bn
6 Alvotech 1.51 Bn 1.36 Bn 2.56 Mn 142.75 Mn
7 Ani Pharmaceuticals 1.48 Bn 1.12 Bn 165.89 Mn 360.21 Mn
8 Amphastar Pharmaceuticals 992.90 Mn 702.78 Mn 93.47 Mn 223.61 Mn
9 Fennec Pharmaceuticals 400.20 Mn 358.95 Mn 17.15 Mn 41.25 Mn
10 RedHill Biopharma 178.79 Mn 178.79 Mn - 3.97 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 886.50 Mn
Mar 31, 2026 1.80 Bn
Dec 31, 2025 1.32 Bn
Sep 30, 2025 975.30 Mn
Jun 30, 2025 566.40 Mn
Mar 31, 2025 755.00 Mn
Dec 31, 2024 736.10 Mn
Sep 30, 2024 1.88 Bn
Jun 30, 2024 917.20 Mn
Mar 31, 2024 1.01 Bn
Dec 31, 2023 991.90 Mn
Sep 30, 2023 1.31 Bn
Jun 30, 2023 629.20 Mn
Mar 31, 2023 506.60 Mn
Dec 31, 2022 1.26 Bn
Sep 30, 2022 646.70 Mn
Jun 30, 2022 664.70 Mn
Mar 31, 2022 752.40 Mn
Dec 31, 2021 706.20 Mn
Sep 30, 2021 756.60 Mn